Works matching AU Park, Chul‐Kee


Results: 113
    1
    2
    3
    4
    5

    SNUH methylation classifier for CNS tumors.

    Published in:
    Clinical Epigenetics, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13148-025-01824-0
    By:
    • Lee, Kwanghoon;
    • Jeon, Jaemin;
    • Park, Jin Woo;
    • Yu, Suwan;
    • Won, Jae-Kyung;
    • Kim, Kwangsoo;
    • Park, Chul-Kee;
    • Park, Sung-Hye
    Publication type:
    Article
    6

    Absolute quantification of tumor-infiltrating immune cells in high-grade glioma identifies prognostic and radiomics values.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 7, p. 1995, doi. 10.1007/s00262-020-02836-w
    By:
    • Kim, A. Reum;
    • Choi, Kyu Sung;
    • Kim, Min-Sung;
    • Kim, Kyung-Min;
    • Kang, Ho;
    • Kim, Sojin;
    • Chowdhury, Tamrin;
    • Yu, Hyeon Jong;
    • Lee, Chae Eun;
    • Lee, Joo Ho;
    • Lee, Soon-Tae;
    • Won, Jae Kyung;
    • Kim, Jin Wook;
    • Kim, Yong-Hwy;
    • Kim, Tae Min;
    • Park, Sung-Hye;
    • Choi, Seung Hong;
    • Shin, Eui-Cheol;
    • Park, Chul-Kee
    Publication type:
    Article
    7
    8
    9

    Prognosis Prediction of Measurable Enhancing Lesion after Completion of Standard Concomitant Chemoradiotherapy and Adjuvant Temozolomide in Glioblastoma Patients: Application of Dynamic Susceptibility Contrast Perfusion and Diffusion-Weighted Imaging.

    Published in:
    PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0113587
    By:
    • Kim, Jae Hyun;
    • Choi, Seung Hong;
    • Ryoo, Inseon;
    • Yun, Tae Jin;
    • Kim, Tae Min;
    • Lee, Se-Hoon;
    • Park, Chul-Kee;
    • Kim, Ji-Hoon;
    • Sohn, Chul-Ho;
    • Park, Sung-Hye;
    • Kim, Il Han
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    IDH2 mutation in gliomas including novel mutation.

    Published in:
    Neuropathology, 2015, v. 35, n. 3, p. 236, doi. 10.1111/neup.12187
    By:
    • Koh, Jaemoon;
    • Cho, Hwajin;
    • Kim, Hannah;
    • Kim, Seong Ik;
    • Yun, Sumi;
    • Park, Chul‐Kee;
    • Lee, Se‐Hoon;
    • Choi, Seung Hong;
    • Park, Sung‐Hye
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 138, n. 3, p. 667, doi. 10.1007/s11060-018-2839-z
    By:
    • Koo, Taeryool;
    • Lim, Do Hoon;
    • Seol, Ho Jun;
    • Park, Chul-Kee;
    • Kim, Il Han;
    • Chang, Jong Hee;
    • Lee, Jeongshim;
    • Jung, Shin;
    • Gwak, Ho-Shin;
    • Cho, Kwan Ho;
    • Hong, Chang-Ki;
    • Lee, Ik Jae;
    • Kim, El;
    • Kim, Jin Hee;
    • Hong, Yong-Kil;
    • Jang, Hong Seok;
    • Kim, Chae-Yong;
    • Kim, In Ah;
    • Kim, Sung Hwan;
    • Kim, Young Il
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50